Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Prepaid Assets: 2019-2025

Historic Prepaid Assets for Keros Therapeutics (KROS) over the last 6 years, with Sep 2025 value amounting to $22.3 million.

  • Keros Therapeutics' Prepaid Assets rose 6.53% to $22.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.3 million, marking a year-over-year increase of 6.53%. This contributed to the annual value of $26.2 million for FY2024, which is 63.84% up from last year.
  • Latest data reveals that Keros Therapeutics reported Prepaid Assets of $22.3 million as of Q3 2025, which was down 16.56% from $26.8 million recorded in Q2 2025.
  • In the past 5 years, Keros Therapeutics' Prepaid Assets ranged from a high of $26.8 million in Q2 2024 and a low of $779,000 during Q1 2021.
  • In the last 3 years, Keros Therapeutics' Prepaid Assets had a median value of $21.0 million in 2024 and averaged $20.1 million.
  • Per our database at Business Quant, Keros Therapeutics' Prepaid Assets plummeted by 34.92% in 2021 and then skyrocketed by 309.76% in 2023.
  • Quarterly analysis of 5 years shows Keros Therapeutics' Prepaid Assets stood at $3.4 million in 2021, then skyrocketed by 97.73% to $6.7 million in 2022, then spiked by 138.18% to $16.0 million in 2023, then soared by 63.84% to $26.2 million in 2024, then rose by 6.53% to $22.3 million in 2025.
  • Its Prepaid Assets stands at $22.3 million for Q3 2025, versus $26.8 million for Q2 2025 and $21.7 million for Q1 2025.